Keywords: everolimus, trial, halted, after, early, pfs, gains

Everolimus trial halted after early PFS gains

Article | 10 March 2008

Print This

Swiss drug major Novartis says that a late-stage Phase III trial of its kidney cancer drug everolimus has been stopped ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in